Toiyama Y - Search Results

1

Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.

Hur K, Toiyama Y, Okugawa Y, Ide S, Imaoka H, Boland CR, Goel A. Hur K, et al. Among authors: toiyama y. Gut. 2017 Apr;66(4):654-665. doi: 10.1136/gutjnl-2014-308737. Epub 2015 Dec 23. Gut. 2017. PMID: 26701878 Free PMC article.

2

Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.

Toiyama Y, Miki C, Inoue Y, Okugawa Y, Koike Y, Watanabe H, Yokoe T, Hiro J, Ojima E, Tanaka K, Kusunoki M. Toiyama Y, et al. J Surg Oncol. 2008 Apr 1;97(5):404-8. doi: 10.1002/jso.20966. J Surg Oncol. 2008. PMID: 18181167

3

Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.

Toiyama Y, Miki C, Inoue Y, Okugawa Y, Koike Y, Yokoe T, Tanaka K, Kusunoki M. Toiyama Y, et al. Ann Surg Oncol. 2008 Jun;15(6):1617-24. doi: 10.1245/s10434-008-9874-5. Epub 2008 Mar 27. Ann Surg Oncol. 2008. PMID: 18368454 Clinical Trial.

4

Decreased expression of monocyte chemoattractant protein-1 predicts poor prognosis following curative resection of colorectal cancer.

Watanabe H, Miki C, Okugawa Y, Toiyama Y, Inoue Y, Kusunoki M. Watanabe H, et al. Among authors: toiyama y. Dis Colon Rectum. 2008 Dec;51(12):1800-5. doi: 10.1007/s10350-008-9380-7. Epub 2008 Jul 17. Dis Colon Rectum. 2008. PMID: 18633677 Clinical Trial.

5

Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.

Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, Tanaka K, Inoue Y, Kusunoki M. Koike Y, et al. Among authors: toiyama y. J Surg Oncol. 2008 Dec 1;98(7):540-4. doi: 10.1002/jso.21154. J Surg Oncol. 2008. PMID: 18937231

6

Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.

Toiyama Y, Miki C, Inoue Y, Kawamoto A, Kusunoki M. Toiyama Y, et al. J Surg Oncol. 2009 May 1;99(6):368-72. doi: 10.1002/jso.21246. J Surg Oncol. 2009. PMID: 19204971

7

Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.

Toiyama Y, Miki C, Inoue Y, Okugawa Y, Tanaka K, Kusunoki M. Toiyama Y, et al. Int J Cancer. 2009 Oct 1;125(7):1657-62. doi: 10.1002/ijc.24554. Int J Cancer. 2009. PMID: 19569242

8

Serum level of soluble vascular cell adhesion molecule 1 is a valuable prognostic marker in colorectal carcinoma.

Okugawa Y, Miki C, Toiyama Y, Koike Y, Inoue Y, Kusunoki M. Okugawa Y, et al. Among authors: toiyama y. Dis Colon Rectum. 2009 Jul;52(7):1330-6. doi: 10.1007/DCR.0b013e3181a0d144. Dis Colon Rectum. 2009. PMID: 19571712

9

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.

Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Ioue Y, Miki C, Kusunoki M. Saigusa S, et al. Among authors: toiyama y. Ann Surg Oncol. 2009 Dec;16(12):3488-98. doi: 10.1245/s10434-009-0617-z. Ann Surg Oncol. 2009. PMID: 19657699

10

Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer.

Yasuda H, Tanaka K, Saigusa S, Toiyama Y, Koike Y, Okugawa Y, Yokoe T, Kawamoto A, Inoue Y, Miki C, Kusunoki M. Yasuda H, et al. Among authors: toiyama y. Oncol Rep. 2009 Oct;22(4):709-17. doi: 10.3892/or_00000491. Oncol Rep. 2009. PMID: 19724847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters